AnaptysBio, Inc.

NASDAQ:ANAB

36.57 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 10.9717.1799.0053.3183.461.3746.8081.2931.2160.971.01120.8930.02711.2476000153050050030702.7543.2145.854.8664.0544.5384.8824.0973.7056.1544.1981.781
Cost of Revenue 0.5950.6050.6040.5920.5870.5930.6060.5850.5710.57326.77622.22125.31424.18521.56719.54217.94820.96821.42629.93127.3520.63115.9217.88310.58311.817.6066.6977.2057.9355.0163.2822.3354.7866.5724.3433.3253.0642.6052.1312.0361.842
Gross Profit 10.3766.5748.4012.7262.8730.7816.2020.7080.6450.397-25.765-1.3314.713-12.93838.433-19.542-17.948-5.968-18.426-29.931-22.35-20.631-15.92-12.883-10.583-11.81-4.606-6.697-0.205-7.935-2.262-0.0683.5150.08-2.5180.1951.5571.0331.14.0232.162-0.061
Gross Profit Ratio 0.9460.9160.9330.8220.830.5680.9110.5480.530.409-25.485-0.0640.157-1.150.64100-0.398-6.1420-4.4700-2.57700-1.5350-0.0290-0.821-0.0210.6010.016-0.6210.0430.3190.2520.2970.6540.515-0.034
Reseach & Development Expenses 41.84336.87933.52530.87832.92334.95723.37422.06420.84422.51626.77622.22125.31424.18521.56719.54217.94820.96821.42629.93127.3520.63115.9217.88310.58311.817.6066.6977.2057.9355.0163.2822.3354.7866.5724.3433.3253.0642.6052.1312.0361.842
General & Administrative Expenses 9.29512.33810.27610.17210.6810.8189.4078.8628.17110.2035.3925.4325.2465.4235.0884.7944.6874.2853.8323.8144.3074.1413.7434.0043.8323.9472.5452.392.352.0530.9121.0071.1521.2191.0740.8890.9440.6820.5740.550.760.47
Selling & Marketing Expenses -0.441-0.4420000000000000000000000000000000000000000
SG&A 8.85411.89610.27610.17210.6810.8189.4078.8628.17110.2035.3925.4325.2465.4235.0884.7944.6874.2853.8323.8144.3074.1413.7434.0043.8323.9472.5452.392.352.0530.9121.0071.1521.2191.0740.8890.9440.6820.5740.550.760.47
Other Expenses 0-0.0027.3390.0010.003-0.004-0.0040.0040.0060.0060.0010.03300.003-0.075-0.0560.0260.094-0.1090.144-0.0410.0070.008-0.04-0.064-0.063-0.1160.4490.310.347-0.2020.1230.07200.034-0.226000.001000
Operating Expenses 50.69748.77543.80141.0543.60345.77532.78130.92629.01532.71932.16827.65330.5629.60826.65524.33622.63525.25325.25833.74531.65724.77219.66321.88714.41515.75710.1519.0879.5559.9885.9284.2893.4876.0057.6465.2324.2693.7463.1792.6810.7740.485
Operating Income -40.321-42.201-42.135-37.732-40.143-44.401-25.973-29.633-27.799-31.749-31.157-6.763-0.533-18.36133.345-24.336-22.635-10.253-22.258-33.745-26.657-24.772-19.663-16.887-14.415-15.757-7.151-9.087-2.555-9.988-3.174-1.0752.363-1.139-3.592-0.6940.6130.3510.5263.4731.402-0.531
Operating Income Ratio -3.675-5.878-4.679-11.372-11.602-32.315-3.815-22.918-22.861-32.731-30.818-0.324-0.018-1.6330.55600-0.684-7.4190-5.33100-3.37700-2.3840-0.3650-1.153-0.3340.404-0.234-0.886-0.1530.1260.0860.1420.5640.334-0.298
Total Other Income Expenses Net -6.33-1.735-0.080.0010.0030.146-0.416-3.869-4.755-4.5060.0010.0330.1040.003-0.075-0.0560.0260.094-0.1090.144-0.0410.0070.008-0.04-0.064-0.063-0.1160.4490.31-1.019-1.2930.0760.0750.3440.285-0.603-0.553-0.613-0.014-0.014-0.637-0.662
Income Before Tax -46.651-43.936-42.215-37.308-39.845-44.255-26.389-33.502-32.554-36.255-32.538-6.666-0.429-18.16333.646-23.767-21.548-8.262-20.285-31.084-24.022-22.097-17.186-15.958-13.618-15.086-6.861-9.09-2.684-11.435-4.578-1.1152.322-0.888-3.423-1.412-0.055-0.3760.5023.4580.765-1.193
Income Before Tax Ratio -4.252-6.12-4.688-11.244-11.516-32.209-3.876-25.91-26.771-37.376-32.184-0.319-0.014-1.6150.56100-0.551-6.7620-4.80400-3.19200-2.2870-0.3830-1.662-0.3470.397-0.182-0.844-0.311-0.011-0.0920.1350.5620.182-0.67
Income Tax Expense 0.0090.5624.8744.4324.3614.190.0243.8694.7554.506-1.45-0.0640-0.195-0.075-0.0560.0260.094-0.022-0.051-0.06-0.019-0.1920.360.3720.3880.2930.9010.7490.775-0.0910.2390.1880.1150.089-0.0610.10.1140.0110.00100
Net Income -46.66-43.936-42.211-37.308-39.845-48.445-26.413-37.371-37.309-40.761-32.538-6.666-0.429-18.16333.646-23.767-21.548-8.262-20.263-31.033-23.962-22.078-16.994-15.958-13.618-15.086-6.861-9.09-2.684-11.435-4.578-1.1152.322-0.888-3.512-1.462-0.055-0.3760.5023.4580.765-1.193
Net Income Ratio -4.253-6.12-4.688-11.244-11.516-35.258-3.88-28.903-30.682-42.022-32.184-0.319-0.014-1.6150.56100-0.551-6.7540-4.79200-3.19200-2.2870-0.3830-1.662-0.3470.397-0.182-0.866-0.322-0.011-0.0920.1350.5620.182-0.67
EPS -1.71-1.64-1.59-1.41-1.5-1.73-0.93-1.32-1.32-1.47-1.18-0.24-0.016-0.661.23-0.87-0.79-0.3-0.75-1.15-0.89-0.82-0.64-0.66-0.57-0.63-0.3-0.45-0.13-0.75-0.3-0.0790.013-0.063-0.036-0.015-0.001-0.0040.0050.0350.31-0.49
EPS Diluted -1.71-1.64-1.59-1.41-1.5-1.73-0.93-1.32-1.32-1.47-1.18-0.24-0.016-0.661.23-0.87-0.79-0.3-0.75-1.15-0.89-0.82-0.63-0.66-0.57-0.63-0.3-0.45-0.13-0.75-0.3-0.0740.012-0.059-0.036-0.015-0.001-0.0040.0050.0350.31-0.48
EBITDA -39.726-41.596-36.653-32.285-34.9-39.919-22.138-26.782-26.115-30.828-31.088-6.0940.378-18.23633.79-23.629-21.411-8.122-20.085-30.709-23.617-21.662-16.821-15.467-13.118-14.581-6.405-8.592-2.194-9.602-3.318-0.8942.495-1.06-3.499-0.8510.670.4250.6023.551.48-0.453
EBITDA Ratio -3.621-5.794-4.07-9.73-10.087-29.053-3.252-20.713-21.476-31.781-30.75-0.2920.013-1.6210.56300-0.541-6.6950-4.72300-3.09300-2.1350-0.3130-1.205-0.2780.426-0.218-0.863-0.1880.1370.1040.1620.5770.353-0.254